Clinical doses of amikacin provide more effective suppression of the human CFTR-G542X stop mutation than gentamicin in a transgenic CF mouse model

Overview of attention for article published in Journal of Molecular Medicine, March 2006

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (69th percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 2 X users

patent: 2 patents

Citations

dimensions_citation: 62 Dimensions

Readers on

mendeley: 50 Mendeley

Summary X Patents Dimensions citations

So far, Dimensions has found 62 publications that cite this research output.

62

The most recent citing publications are shown below. View all 62 publications that cite this research output on Dimensions.

Small molecule modulators of cystic fibrosis transmembrane conductance regulator (CFTR): Structure, classification, and mechanisms

Article in European Journal of Medicinal Chemistry (January 2024)

One Size Does Not Fit All: The Past, Present and Future of Cystic Fibrosis Causal Therapies

Article in Cells (June 2022)

NanoLuc reporters identify COL4A5 nonsense mutations susceptible to drug-induced stop codon readthrough

Article in iScience (February 2022)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.